145767-78-8

Basic information

• Product Name: 5-Bromo-1,3-difluoro-2-(2,2,2-trifluoroethoxy)benzene
• Synonyms: 5-Bromo-1,3-difluoro-2-(2,2,2-trifluoroethoxy)benzene;5-Bromo-1,3-difluoro-2-(2,2,2-trifluoroethocy)benzene
• CAS NO: 145767-78-8
• Molecular Formula: C₈H₄BrF₅O
• Molecular Weight: 291.012776
• Mol File: 145767-78-8.mol

Chemical Properties

• Boiling Point: 218.2±40.0 °C(Predicted)
• Appearance: /
• Density: 1.702±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 5-Bromo-1,3-difluoro-2-(2,2,2-trifluoroethoxy)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-1,3-difluoro-2-(2,2,2-trifluoroethoxy)benzene(145767-78-8)
• EPA Substance Registry System: 5-Bromo-1,3-difluoro-2-(2,2,2-trifluoroethoxy)benzene(145767-78-8)

Safety Data

• Hazardous Substances Data: 145767-78-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
5-Bromo-1,3-difluoro-2-(2,2,2-trifluoroethoxy)benzene is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 5-Bromo-1,3-difluoro-2-(2,2,2-trifluoroethoxy)benzene serves as an essential component in the creation of agrochemicals, potentially enhancing crop protection and yield through its incorporation into various chemical formulations.
Used in Organic Synthesis:
5-Bromo-1,3-difluoro-2-(2,2,2-trifluoroethoxy)benzene is utilized as a building block in organic synthesis, allowing for the construction of a wide range of organic compounds with diverse applications across various industries.
Used in Research and Development:
5-Bromo-1,3-difluoro-2-(2,2,2-trifluoroethoxy)benzene is also employed in research and development efforts, where its unique structure and properties are explored for potential new applications and to advance the understanding of organic chemistry.

Upstream product

• 6226-25-1 2,2,2-trifluoroethyl trifluoromethanesulphonate 
• 104197-13-9 4-bromo-2,6-difluorophenol 
• 433-06-7 2,2,2-Trifluoroethyl p-toluenesulfonate 

Downstream Products

• 801303-44-6 3,5-difluoro-4-(2,2,2-trifluoroethoxy)benzonitrile 
• 160483-71-6 C₈H₆BF₅O₃ 

Relevant articles and documents

LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE

PROBLEM TO BE SOLVED: To provide a liquid crystal compound, a liquid crystal composition, and a liquid crystal device using the compound or the composition. SOLUTION: The liquid crystal compound is represented by formula (I). In formula (I), R1 represents H, an alkyl having 1 to 10 carbon atoms, or the like; R2 represents an alkenyl having 2 to 10 carbon atoms or a fluoroalkenyl having 2 to 10 carbon atoms and one or two non-adjacent -CH2- in R2 is replaced by -O- or an ether having 2 to 10 carbon atoms; A1 to A4 each independently represent a formula below, where R3 independently represents H or a halogen; Z1 to Z3 each independently represents a sing bond, -CH2-, -CH2O-, -OCH2-, -CF=CF-, -COO-, -OCO-, -CF2O-, -OCF2-, -C≡C-, -CH=CH-, or the like; and n and m each independently represent 0 or 1. SELECTED DRAWING: None COPYRIGHT: (C)2016,JPOandINPIT

3,5-ARYL, HETEROARYL OR CYCLOALKYL SUBSTITUTED-1,2,4-OXADIAZOLES AS S1P RECEPTOR AGONISTS

The present invention encompasses compounds of Formula I: (I) as well as the pharmaceutically acceptable salts thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejecti